Suite 1300
Salt Lake City, UT 84111
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram,
Tamil Nadu – 605602
Re-authorization Management
Re-authorization Tracked Before
Expiry, Not After Therapy Stops
Proactive re-authorization submission 30–45 days before expiry across all major commercial, Medicare Advantage, Medicaid, and managed Medicaid plans. Prevents therapy interruption, eliminates the revenue gaps that lapsed authorizations cause, and keeps specialty patients on continuous care.
30–45 DAY
Submission Window
98%+
On-time Renewal Rate
ZERO
Therapy Gap Target
The Reality
Why lapsed re-authorizations quietly become the biggest continuing-patient revenue leak?
Re-authorization is the part of specialty pharmacy operations most likely to fail silently. Initial PAs get attention because therapy starts depend on them; re-auths happen on continuing patients who are already on therapy, so the urgency feels lower. Until the auth expires.
Silent Expiry Risk
Re-authorization windows close without warning. Pharmacies running re-auth workflows without active expiry tracking don't discover lapsed authorizations until claims start denying — typically 30–60 days after the patient should have been re-authorized.
Payer Policy Drift
Re-authorization criteria change between approval cycles. A patient approved last quarter under one set of clinical criteria may face new step therapy requirements, formulary changes, or medical necessity standards at renewal. Generic re-auth submissions fail at high rates.
Therapy Continuity Pressure
Specialty therapy interruption has clinical consequences — oncology regimens disrupted, biologics restarted from baseline, transplant patients on borrowed inventory. The pharmacy carries both the clinical risk and the revenue impact when re-auth fails.
Volume Compounds Over Time
A specialty pharmacy with 800 active patients on biologic therapy is managing 800 re-authorization cycles annually. Without dedicated infrastructure, the volume becomes unmanageable, and re-auth quality degrades as the team prioritizes initial PAs over renewals.
Documentation Drift Across Cycles
Clinical documentation supporting the initial PA approval ages over time. Lab results from 14 months ago, prescriber attestations from before a treatment change, and prior treatment history that's now incomplete — all of which weaken re-authorization submissions if not refreshed.
Continuing Patient Revenue Concentration
Continuing patients on high-cost specialty therapy represent the highest-margin revenue in the practice. A single oncology patient on continuing biologic therapy can represent $200K–$600K in annual revenue. Losing that revenue to a lapsed re-auth is a structural margin event.
Our approach
We run re-authorization as a standing operation, not an afterthought
AnnexMed runs re-authorization as a dedicated operation separate from initial PA submission — with its own team, its own expiry-tracking infrastructure, and its own clinical refresh workflow. Re-auths get submitted 30–45 days before expiry with current clinical evidence, payer policy verification, and prescriber attestation refresh.
We serve specialty pharmacies, infusion centers, and home infusion providers where continuing-patient revenue represents the bulk of the practice. Our re-auth team understands the difference between a routine renewal and a renewal that’s about to face new step therapy requirements — and we treat each accordingly.
Recent client results
A specialty pharmacy managing 1,400 active biologic patients reduced re-authorization lapse rate from 11% to 0.6% within 90 days of go-live, preventing approximately $2.3M in continuing-patient revenue interruption annually. A regional infusion provider serving 320 oncology patients eliminated therapy gaps entirely across 18 months of partnership through proactive expiry tracking and 30-day pre-submission cadence. A home infusion provider with 14 service areas recovered $480,000 in revenue previously written off to lapsed authorizations through historical re-auth audit and retroactive recovery work.
98%+
On-Time Re-authorization Rate
30–45 days
Pre-Expiry Submission
Window
Zero
Therapy Gap
Target
How we support you
End-to-End Re-authorization operation
Expiry Tracking
Proactive renewal pipeline
- PA expiry calendar across all active patients
- 30/45/60 day pre-expiry alerts
- Payer-specific renewal window tracking
- Patient-level renewal status visibility
- Census reconciliation against active therapy
- Renewal pipeline dashboards for clinical staff
Clinical Refresh
Documentation update for renewal
- Current lab result coordination
- Treatment response documentation refresh
- Prescriber attestation re-collection
- Payer policy change verification
- Step therapy or formulary update review
- Adherence and outcomes documentation
Submission & Escalation
Renewal completion through approval
- Payer-specific re-authorization submission
- Status tracking through adjudication
- Renewal denial escalation to appeals workflow
- Peer-to-peer coordination on contested renewals
- Approval documentation and patient notification
- Next-cycle expiry calendar update
Financial impact
What Re-authorization discipline means in dollars?
Fast Results
Built for Continuing Patient Economics
Improvement Area
Estimated Annual Impact
Lapsed Re-authorization Prevention
$800K – $2.5M annually in retained continuing-patient revenue
Therapy Gap Elimination
$200K – $700K in prevented patient abandonment
Historical Lapsed Auth Recovery (first 6 months)
$300K – $1M in one-time retroactive revenue capture
Renewal Denial Reduction
$200K – $600K annually in successful first-pass renewals
Peer-to-Peer Renewal Capture
$100K – $400K annually in escalated renewal approvals
Clinical Refresh Quality Lift
$150K – $500K annually in payer-aligned renewals
Staffing Cost Reduction / Replacement
$200K – $500K annually
Re-Authorization performance targets
Performance Metric
Industry Benchmark
AnnexMed Target
On-Time Re-authorization Rate
Specialty avg: 78–86%
98%+
Pre-Expiry Submission Window
Industry standard: 5–14 days
30–45 days
Lapsed Authorization Rate
Specialty avg: 9–15%
< 2%
Therapy Gap Incidents
Specialty avg: 1.8 per 100 patients
Zero target
First-Pass Renewal Approval
Specialty avg: 72–82%
92%+
Renewal Denial Overturn Rate
Specialty avg: 45–58%
85%+
Clinical Refresh Completeness
Industry varies widely
98%+
Continuing Patient Revenue Retention
Industry avg: 87–93%
99%+
Why AnnexMed?
In-house re-authorization vs. AnnexMed operation
In-House / Traditional
AnnexMed Partnership
Expiry Tracking
Manual calendar; missed expiries discovered through denials
Active expiry pipeline with 30/45/60-day alerts and dashboards
Submission Window
5–14 days pre-expiry; no buffer for adjudication
30–45 days pre-expiry with renewal-cycle buffer
Clinical Refresh
Re-uses initial PA documentation; aged evidence weakens approval
Active clinical refresh with current labs, attestations, outcomes
Payer Policy Changes
Discovered through renewal denials
Tracked proactively with quarterly payer policy verification
Lapsed Auth Treatment
Therapy gap; patient abandons or restarts from baseline
Zero therapy gap target with proactive pipeline management
Renewal Denial Recovery
Limited; many denials written off after lapse
Appeals workflow with peer-to-peer and external review escalation
Historical Recovery
No retroactive recovery on past lapses
Six-month historical audit with retroactive submission workflow
Cost to Operate
$85K–$130K per FTE for PA specialist
30–40% lower with no hiring, attrition, or training overhead
Technology
Powered by proprietary AI & analytics
AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.
AI Agents & Automation
AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.
Data & Analytics Platform
Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.
Intelligent AR Management
Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.
Computer Assisted Coding
Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.
Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.
Ready to stop losing continuing-patient revenue to lapsed re-authorizations?
Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant
Payer client outcomes
$15M–$40M
Risk
Adjustment
$18M–$50M
Payment
Integrity
6 Weeks
Credentialing Clearance
$15M–$50M+
Revenue
Impact
Case Studies
See the impact we deliver
Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.
Client Voices
See how our clients succeed
Proven RCM expertise. Delivered at scale.
For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.
- 20+ years of proven healthcare RCM experience
- 1,500+ professionals supporting billing, coding & AR
- 500+ certified coders across multiple specialties
- 99%+ compliance with HIPAA and security standards
- All 50 states served with consistent, scalable operations
